Skip to content
GLP-1 Scorecard
Menu
Graded #335

Invyncible

Invyncible is a Florida-based telehealth platform whose semaglutide and tirzepatide programs are each priced on the public catalog, with six named compounding pharmacies behind them.

Visit InvyncibleWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$149/mo (0.45 mg dose, compounded with glycine + B12)
Tirzepatide
$180/mo (2.5 mg weekly, 4-week program, compounded)
Coverage
46 states plus DC
Brand-name
Yes

Weigh Invyncible against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value55/100
Dose & formulation64/100
Clinical oversight70/100
Labs & monitoring52/100
Fulfillment65/100
Contract terms61/100

Strengths

  • Publishes the price of every dose program openly, with no account and no intake first
  • Names its six compounding pharmacies with addresses and phone numbers and lets patients choose between them, or bring their own
  • Marks compounded against FDA-approved brand and injection against oral on the catalog itself — Wegovy $1,750, Zepbound $1,540, oral capsules $255.50
  • Refills are requested rather than auto-billed, and the card is charged only on provider approval
  • Corporate parent disclosed (Nationwide Telemedicine, LLC) with a published St. Petersburg, FL address and a working LegitScript link

Where it loses points

  • The advertised figure is the starter vial — plain compounded semaglutide reaches $262.50 and then $350 as the vial size grows, per the site's own FAQ
  • Every listed price is struck through from a higher one that never expires, which is anchoring rather than a discount
  • The six named pharmacies are named without a 503A or 503B designation anywhere
  • Shipping cost is unpublished and refrigerated programs get only overnight cold shipping
  • Six states lose compounded semaglutide and seven lose tirzepatide, against a 46-state company footprint

Bottom line — Grade C

Best for: Shoppers who want to compare a published price and a named pharmacy before handing over any details.

Ranked #335 of 544 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Invyncible — the realistic shortlist.

The 18 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Invyncible's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Invyncible's site. Not medical advice; see our disclosure.

← Back to the scorecard